Research News - Goda Lab Reaches Final Phase of XPRIZE Healthspan Competition With Super

Goda Lab developed proprietary "super exosomes"- tiny natural particles that cells use to transport biological materials - by chemically engineering the surface of exosomes with lanthanide ions, dramatically enhancing their ability to target senescent cells. Senescent cells are old or damaged cells that have.

Once attached to senescent cells, the super exosomes efficiently deliver regenerative molecular cargo, such as growth factors or genetic material, directly to aging tissues, helping to promote repair where it is needed most. In preclinical studies involving multiple cohorts of aged mice, super exosomes.

What Happened

The overall benefit corresponds to an estimated extension of more than 15 healthy human years based on accepted cross-species lifespan scaling. To build on these findings, the team will launch clinical studies in collaboration with Tohoku University Hospital and the Tohoku University.

• "We look forward to validating this approach in human clinical studies and bringing its benefits to society."

• The team plans to commercialize the technology through NanoTitan.

• Beyond healthy aging, the platform has potential applications in preserving cognitive, muscular, and immune function, as well as hair regeneration, skin rejuvenation, and reproductive medicine.

Key Details

The goal is to demonstrate that the technology can extend healthy human lifespan by at least ten years, the benchmark required to compete for the XPRIZE Grand Prize.

What Reports Say

Coverage of the story so far points to:

• Continued reporting by tohoku.ac.jp as more details emerge